Ann: Appendix 4C - quarterly, page-147

Other than the obvious way better margins on Cochlear products, Cochlear differs from AHZ in one other important way.

It was capitalised and funded properly from the outset.

It was never floated until then.

Pac Pun put in all the ground work and paid for that way before mere mortal punters like me and everyone else were asked to "put their hard earned" into it.....

Oh I realise all this now... Gatsby you bloody fool...

That's why nobody wants to take over AHZ.. They see there is a heck of load more capital required..so why not let another bunch of suckers chip in some more before offering a bid?

Whilst the Chinese may well have the stomach for loads more cash, and pull it off moving it to China, there is also the risk that it will be ballsed up some more, and by the time it's all sorted the patents have expired anyway...

We are already years into the Cardiocel patent are we not?

Companies like this don't have endless time to pull it all off...

Like I said it should of been held private for years before floating it, or if they did float it early, it should have been capitalised way more than it was with REAL skin in the game...

Worst case scenario?

Probably... but who knows?

Just my IMO!